Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltitrexed vs 5-FU in Colorectal Cancer Liver Metastasis
NCT02453490Phase 3Terminated
- Sponsor
- Zhejiang University
- Start
- Oct 2015
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltitrexed in colorectal cancer (CRC), liver metastases, sponsored by Zhejiang University. Started Oct 2015; status: terminated.
02
Drugs
raltitrexed
03
Conditions
colorectal cancer (CRC)liver metastases
Beyond the preview
Go deeper on NCT02453490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453490.